The United States Food and Drug Administration (FDA) approved the drug flibanserin (sold under the brand name Addyi) for the treatment of women with hypo-active sexual desire disorder (HSDD) in August 2015. Australia hasn’t followed suit, though flib
When the dad-bod phenomenon went viral last spring, I covered my eyes and ears. And I held my nose, too, because frankly, this trend stinks. Substitute a letter and you get “bad bod.” Coincidence? I don’t think so.